Filtreeri Last updated date SelectPärastEnneFrom - To Date Lõppkuupäev This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Tulemused (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 september 2023NewsHumanCOVID-19Medicines PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 september 2023NewsHumanReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 september 2023NewsHumanPharmacovigilanceReferrals Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 30 august 2023NewsHumanCOVID-19Medicines EMA review of data on paternal exposure to valproate 16 august 2023Press releaseHuman EMA mourns passing of Noël Wathion 14 august 2023NewsCorporate EMA business hours over Assumption Day, 15 August 11 august 2023NewsCorporateCOVID-19Mpox Paving the way towards coordinated clinical trials in public health emergencies in the EU 25 juuli 2023NewsHumanClinical trials Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023 21 juuli 2023NewsHumanCOVID-19MedicinesReferrals First RSV vaccine to protect infants up to 6 months of age and older adults 21 juuli 2023NewsHumanMedicinesVaccines 1 … 28 29 30 31 32 Page 32 of 385 33 34 35 36 … 385
Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 september 2023NewsHumanCOVID-19Medicines
PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 september 2023NewsHumanReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 september 2023NewsHumanPharmacovigilanceReferrals
Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 30 august 2023NewsHumanCOVID-19Medicines
Paving the way towards coordinated clinical trials in public health emergencies in the EU 25 juuli 2023NewsHumanClinical trials
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023 21 juuli 2023NewsHumanCOVID-19MedicinesReferrals
First RSV vaccine to protect infants up to 6 months of age and older adults 21 juuli 2023NewsHumanMedicinesVaccines